Akoya Biosciences Latest News
- 03-11 AInvest WireQuanterix Shareholder Opposes Proposed Akoya Biosciences Merger
- 03-11 AInvest WireAkoya Biosciences shares rise 4.22% intraday after Kent Lake's opposition to Quanterix's proposed transaction.
- 03-05 MarketWatchHold Rating on Quanterix-Akoya Merger Amid Uncertainties and Potential Synergies
- 03-05 MarketWatchAkoya Biosciences downgraded to Neutral from Overweight at Piper Sandler
- 03-05 AInvest NewsInsider Transactions Reported | Akoya Biosciences(AKYA)saw insider trading activity on 3/4/2025
- 03-03 AInvest WireQuanterix highlights benefits of Akoya Biosciences acquisition, reiterates strategic value.
- 03-03 AInvest WireQuanterix shareholder nominates board candidates, opposes Akoya merger
- 02-18 AInvest WireQuanterix Shareholders Oppose Proposed Merger with Akoya Biosciences
- 02-15 AInvest WireMonteverde & Associates PC Investigating Proposed Mergers - EVGR, QTRX, RKDA, EBTC
- 02-05 MarketWatchAkoya Biosciences unveils strategic product roadmap
- 02-05 AInvest WireAkoya Biosciences Unveils Ambitious Spatial Proteomics Roadmap with IO60 and Neurobiology Panels
- 02-05 NasdaqAkoya Biosciences Unveils Strategic Product Roadmap, Powered by the New IO60 and Upcoming Neurobiology Panels
- 02-04 AInvest WireEnveric Biosciences Licenses Technology to Restoration Biologics for Joint Disease Treatments.
- 01-29 AInvest WireAkoya Biosciences shares fall 8.00% after-hours following manufacturing partnership announcement.
- 01-28 MarketWatchAkoya Biosciences selects Argonaut Manufacturing as IVD manufacturing partner
- 01-25 MarketWatchAnalysts Offer Insights on Healthcare Companies: Akoya Biosciences (AKYA) and HCA Healthcare (HCA)
- 01-23 AInvest WireInvestigating Potential Violations of Federal Securities Laws and Breaches of Fiduciary Duties.
- 01-15 AInvest WireQuanterix reports Q4 revenue of $34.9M, up 7th straight quarter of double-digit growth.
- 01-14 AInvest WireAkoya Biosciences shares down 8.87% premarket after merger announcement.
Show More News